This week on MIP: Spruson & Ferguson and East IP exclusives | MoFo exits China

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: Spruson & Ferguson and East IP exclusives | MoFo exits China

beijing-east-ip-adobestock-226677154.jpg

We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP

Exclusive: Spruson & Ferguson hires new Asia MD

Spruson and Ferguson has hired a new managing director for Asia after former leader Kristian Robinson resigned in February, Managing IP revealed.

Singapore-based Duarte Lima, who previously worked at business school INSEAD in different roles, most recently as chief of staff, will lead Spruson and Ferguson’s Asia operations.

To read the full article, click here.

Exclusive: East IP hires Asia veteran as expansion continues

Newly formed China-based firm East IP hired Tom Treutler, a former managing partner at Tilleke & Gibbins, as a senior consultant.

Treutler has spent more than 25 years in Asia working with international and regional law firms. He joined East IP yesterday, June 20. He worked in the Vietnam office of the law firm Tilleke & Gibbins until January this year.

To read the full article, click here.

‘Bullshit in is bullshit out’: practitioners urge EPO quality drive

Practitioners from in-house and academia, as well as a judge at the Unified Patent Court, have outlined why high-quality patents are so important for legal certainty amid some concern that the EPO is prioritising grant rates and productivity over quality.

Speakers from Siemens, Ericsson, Syngenta, and a judge at the Munich division of the UPC formed part of a conference held in Germany, and broadcast online, by the Industry Patent Quality Charter.

To read the full article, click here.

Other articles published on Managing IP this week include:

What does WIPO’s TK treaty mean for patent strategies?

Five minutes with…Julia Holden, Trevisan & Cuonzo

Introducing the Social Impact Americas Awards' inaugural judges panel

Weekly take: Why INTA shouldn’t go to Dubai in 2029

The UPCLA: A coordinated response to Europe’s patent revolution

Ready to act: Chilean firms reveal AI and data privacy focus

One-year retirement: US lawyer reveals career break benefits

Elsewhere in IP

Scotch guard

The Brazilian Patent and Trademark Office (INPI) has granted a Geographical Indication (GI) for Scotch, referring to whisky produced in Scotland. The registration, granted on June 18, is the first foreign GI registered by INPI since 2019, and the 124th in total.

Amazon off target

Amazon was ordered to pay nearly $122 million for infringing a patent owned by AlmondNet related to targeted internet advertising technology, the District Court for the Western District of Texas ruled on Friday, June 14. A jury at the Waco court agreed with patent owner AlmondNet that elements of Amazon's advertising platform infringed two patents related to personalised ad targeting.

Brexit case

The Court of Justice of the EU dismissed an appeal filed by the EUIPO on Thursday, June 20, in a case surrounding the UK’s EU exit and a figurative EU Trademark containing the word ‘Basmati’.

UK food company Indo European Foods had opposed a third party’s EUTM application. The Boards of Appeal rejected Indo’s opposition prompting Indo to file an action at the General Court (GC). During the GC proceedings, the Brexit transition period expired, meaning UK rights ceased to have effect in the EU.

The EUIPO argued that Indo’s action had therefore become inadmissible for loss of legitimate interest. The GC, and now the CJEU, disagreed.

Let’s talk


The EUIPO announced on Thursday, June 20 that parties involved in EU trademark (EUTM) cancellation proceedings will soon be able to request mediation. The service, which can be requested at any time after a cancellation request is filed, will be available from July 1.


INTA award

INTA has received the 2024 Association Award from the Global Anti-Counterfeiting Group (GACG), the association announced on Tuesday, June 18. The GACG is an international network of national and regional IP protection and enforcement organisations.

China exit

Morrison Foerster is to close its Beijing office, reportedly due to "manpower consolidation" and lease expiration, it was reported on Wednesday, June 19. The office has 4 lawyers in total, including two who work in IP transactions.

That's it for today, see you again next week.

more from across site and SHARED ros bottom lb

More from across our site

Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
Gift this article